Page last updated: 2024-11-06

mitomycin and Orphan Diseases

mitomycin has been researched along with Orphan Diseases in 3 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Orphan Diseases: Rare diseases that have not been well studied.

Research Excerpts

ExcerptRelevanceReference
"Conjunctival melanoma is extremely rare in children and has low rates of resolution."1.72Fluorescent in situ hybridization (FISH): A useful diagnostic tool for childhood conjunctival melanoma. ( María Moral, R; María Peiró, A; Monteagudo, C; Moreno, L; Muriel, J, 2022)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
María Moral, R1
Monteagudo, C1
Muriel, J1
Moreno, L1
María Peiró, A1
Sio, TT1
Vu, CC1
Sohawon, S1
Van Houtte, P1
Thariat, J1
Novotny, PJ1
Miller, RC1
Bar-Sela, G1
Camp-Sorrell, D1

Reviews

1 review available for mitomycin and Orphan Diseases

ArticleYear
Hemolytic uremic syndrome.
    Oncology nursing forum, 2008, Volume: 35, Issue:4

    Topics: Adult; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antihypertensive Agents; Anus Neoplasm

2008

Other Studies

2 other studies available for mitomycin and Orphan Diseases

ArticleYear
Fluorescent in situ hybridization (FISH): A useful diagnostic tool for childhood conjunctival melanoma.
    European journal of ophthalmology, 2022, Volume: 32, Issue:6

    Topics: Child; Conjunctival Neoplasms; Humans; In Situ Hybridization, Fluorescence; Melanoma; Mitomycin; Rar

2022
Extraskeletal Osteosarcoma: An International Rare Cancer Network Study.
    American journal of clinical oncology, 2016, Volume: 39, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc

2016